No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 6, 2006, Pages

  Magkos, Faidon ^a,b   Patterson, Bruce W ^a   Mittendorfer, Bettina ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Lipid; Sex hormones; Stable isotope

Indexed keywords

APOLIPOPROTEIN B100; FATTY ACID; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CALORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; KINETICS; LUTEAL PHASE; MENSTRUAL CYCLE; METABOLIC RATE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEIN B-100; CALORIMETRY, INDIRECT; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FATTY ACIDS, NONESTERIFIED; FEMALE; FOLLICULAR PHASE; GLYCEROL; HUMANS; KINETICS; LEUCINE; LIPASE; LIPOPROTEINS, VLDL; LIVER; LUTEAL PHASE; MAGNETIC RESONANCE SPECTROSCOPY; MENSTRUAL CYCLE; PALMITATES; PARTICLE SIZE; PROGESTERONE; TRIGLYCERIDES;

EID: 33845462873     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00246.2006     Document Type: Article

References (62)

1. Aarsland A, Chinkes D, and Wolfe RR. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest 98: 2008-2017, 1996.
2. Ahumada Hemer H, Valles de Bourges V, Juarez Ayala J, Brito G, Diaz-Sanchez V, and Garza-Flores J. Variations in serum lipids and lipoproteins throughout the menstrual cycle. Fertil Steril 44: 80-84, 1985.
3. Applebaum DM, Goldberg AP, Pykalisto OJ, Brunzell JD, and Hazzard WR. Effect of estrogen on postheparin lipolytic activity. Selective decline in hepatic triglyceride lipase. J Clin Invest 59: 601-608, 1977.
4. Azogui G, Ben-Shlomo I, Zohar S, Kook A, Presser S, and Aviram M. High density lipoprotein concentration is increased during the ovulatory phase of the menstrual cycle in healthy young women. Gynecol Endocrinol 6: 253-257, 1992.
5. Barrows BR and Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab 91: 1446-1452, 2006.
6. Bensadoun A. Sandwich immunoassay for measurement of human hepatic lipase. Methods Enzymol 263: 333-338, 1996.
7. Berr F, Eckel RH, and Kern F Jr. Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women. J Lipid Res 27: 645-651, 1986.
8. Brideau NA, Forest JC, Lemay A, and Dodin S. Correlation between ovarian steroids and lipid fractions in relation to age in premenopausal women. Clin Endocrinol (Oxf) 37: 437-444, 1992.
9. Campos H, Walsh BW, Judge H, and Sacks FM. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab 82: 3955-3963, 1997.
10. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88: 2404-2411, 2003.
11. Colvin PL Jr, Auerbach BJ, Case LD, Hazzard WR, and Applebaum-Bowden D. A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women. Metabolism 40: 1052-1056, 1991.
12. Cryer A. Tissue lipoprotein lipase activity and its action in lipoprotein metabolism. Int J Biochem 13: 525-541, 1981.
13. De Leon RG, Austin KL, Richards L, and Guerrero F. Lipid and hormonal profile of Panamanian women during the menstrual cycle. Int J Gynaecol Obstet 39: 219-226, 1992.
14. Faix D, Neese R, Kletke C, Wolden S, Cesar D, Coutlangus M, Shackleton CH, and Hellerstein MK. Quantification of menstrual and diurnal periodicities in rates of cholesterol and fat synthesis in humans. J Lipid Res 34: 2063-2075, 1993.
15. Fallat R and Glueck CJ. Effects of anabolic and progestational agents upon triglycerides and triglyceride kinetics in normals and hyperlipemic patients. Lipids 9: 117-120, 1974.
16. Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, Wagenknecht LE, and Haffner SM. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 111: 3465-3472, 2005.
17. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634, 1983.
18. Glueck CJ, Fallat RW, and Scheel D. Effects of estrogenic compounds on triglyceride kinetics. Metabolism 24: 537-545, 1975.
19. Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 75: 898-915, 2001.
20. Heiling VJ and Jensen MD. Free fatty acid metabolism in the follicular and luteal phases of the menstrual cycle. J Clin Endocrinol Metab 74: 806-810, 1992.
21. Hellerstein MK, Christiansen M, Kaempfer S, Kletke C, Wu K, Reid JS, Mulligan K, Hellerstein NS, and Shackleton CH. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest 87: 1841-1852, 1991.
22. Hewitt KN, Pratis K, Jones ME, and Simpson ER. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 145: 1842-1848, 2004.
23. Hokanson JE and Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3: 213-219, 1996.
24. Horton TJ, Miller EK, and Bourret K. No effect of menstrual cycle phase on glycerol or palmitate kinetics during 90 min of moderate exercise. J Appl Physiol 100: 917-925, 2006.
25. Joles JA, Bijleveld C, van Tol A, Geelen MJ, and Koomans HA. Ovariectomy decreases plasma triglyceride levels in analbuminaemic rats by lowering hepatic triglyceride secretion. Atherosclerosis 117: 51-59, 1995.
26. Kannel WB and Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 155: 57-61, 1995.
27. Kekki M and Nikkila EA. Plasma triglyceride turnover during use of oral contraceptives. Metabolism 20: 878-889, 1971.
28. Kissebah AH, Harrigan P, and Wynn V. Mechanism of hypertriglyceridaemia associated with contraceptive steroids. Horm Metab Res 5: 184-190, 1973.
29. Kobayashi J, Hashimoto H, Fukamachi I, Tashiro J, Shirai K, Saito Y, and Yoshida S. Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clin Chim Acta 216: 113-123, 1993.
30. Lewis GF. Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 8: 146-153, 1997.
31. Lindberg UB, Crona N, Silfverstolpe G, Bjorntorp P, and Rebuffe-Scrive M. Regional adipose tissue metabolism in postmenopausal women after treatment with exogenous sex steroids. Horm Metab Res 22: 345-351, 1990.
32. Lussier-Cacan S, Xhignesse M, Desmarais JL, Davignon J, Kafrissen ME, and Chapdelaine A. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy. Metabolism 40: 849-854, 1991.
33. Lyons Wall PM, Choudhury N, Gerbrandy EA, and Truswell AS. Increase of high-density lipoprotein cholesterol at ovulation in healthy women. Atherosclerosis 105: 171-178, 1994.
34. Magkos F, Wright DC, Patterson BW, Mohammed BS, and Mittendorfer B. Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men. Am J Physiol Endocrinol Metab 290: E355-E362, 2006.
35. Mattsson LA, Silfverstolpe G, and Samsioe G. Lipid composition of serum lipoproteins in relation to gonadal hormones during the normal menstrual cycle. Eur J Obstet Gynaecol Reprod Biol 17: 327-335, 1984.
36. Mittendorfer B, Liem O, Patterson BW, Miles JM, and Klein S. What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes 52: 1641-1648, 2003.
37. Mittendorfer B, Patterson BW, and Klein S. Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity. Am J Physiol Endocrinol Metab 284: E549-E556, 2003.
38. Mittendorfer B, Patterson BW, Klein S, and Sidossis LS. VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am J Physiol Endocrinol Metab 284: E708-E715, 2003.
39. Mittendorfer B and Sidossis LS. Mechanism for the increase in plasma triacylglycerol concentrations after consumption of short-term, high-carbohydrate diets. Am J Clin Nutr 73: 892-899, 2001.
40. Muesing RA, Forman MR, Graubard BI, Beecher GR, Lanza E, McAdam PA, Campbell WS, and Olson BR. Cyclic changes in lipoprotein and apolipoprotein levels during the menstrual cycle in healthy premenopausal women on a controlled diet. J Clin Endocrinol Metab 81: 3599-3603, 1996.
41. National Cholesterol Education Program. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 106: 3143-3421, 2002.
42. Pahwa MB, Seth S, and Seth RK. Lipid profile in various phases of menstrual cycle and its relationship with percentage plasma volume changes. Clin Chim Acta 273: 201-207, 1998.
43. Patterson BW, Mittendorfer B, Elias N, Satyanarayana R, and Klein S. Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover. J Lipid Res 43: 223-233, 2002.
44. Patterson BW, Zhao G, Elias N, Hachey DL, and Klein S. Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res 40: 2118-2124, 1999.
45. Rebuffe-Scrive M, Enk L, Crona N, Lonnroth P, Abrahamsson L, Smith U, and Bjorntorp P. Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest 75: 1973-1976, 1985.
46. Reichl D. Lipoproteins of human peripheral lymph. Eur Heart J 11, Suppl E: 230-236, 1990.
47. Roncero C, Lorenzo M, Fabregat I, and Benito M. Rates of lipogenesis in fetal hepatocytes in suspension and in primary culture: hormonal effects. Biochim Biophys Acta 1012: 320-324, 1989.
48. Sacks FM and Walsh BW. Sex hormones and lipoprotein metabolism. Curr Opin Lipidol 5: 236-240, 1994.
49. Schaefer EJ, Lamon-Fava S, Spiegelman D, Dwyer JT, Lichtenstein AH, McNamara JR, Goldin BR, Woods MN, Morrill-LaBrode A, Hertzmark E, Longcope C, and Gorbach SL. Changes in plasma lipoprotein concentrations and composition in response to a low-fat, high-fiber diet are associated with changes in serum estrogen concentrations in premenopausal women. Metabolism 44: 749-756, 1995.
50. Schectman G and Sasse E. Variability of lipid measurements: relevance for the clinician. Clin Chem 39: 1495-1503, 1993.
51. Sidossis LS, Mittendorfer B, Walser E, Chinkes D, and Wolfe RR. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am J Physiol Endocrinol Metab 275: E798-E805, 1998.
52. Tikkanen MJ, Kuusi T, Nikkila EA, and Sane T. Very low density lipoprotein triglyceride kinetics during hepatic lipase suppression by estrogen. Studies on the physiological role of hepatic endothelial lipase. FEBS Lett 181: 160-164, 1985.
53. Tikkanen MJ, Kuusi T, Nikkila EA, and Stenman UH. Variation of postheparin plasma hepatic lipase by menstrual cycle. Metabolism 35: 99-104, 1986.
54. Tikkanen MJ, Nikkila EA, Kuusi T, and Sipinen SU. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. J Clin Endocrinol Metab 54: 1113-1117, 1982.
55. Wahl PW, Warnick GR, Albers JJ, Hoover JJ, Walden CE, Bergelin RO, Ogilvie JT, Hazzard WR, and Knopp RH. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use - the Pacific Northwest Bell Telephone Company health survey. Atherosclerosis 39: 111-124, 1981.
56. Walsh BW and Sacks FM. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. J Clin Invest 91: 2126-2132, 1993.
57. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, and Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325: 1196-1204, 1991.
58. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109: 1-9, 1949.
59. Wolfe BM and Huff MW. Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women. J Clin Invest 83: 40-45, 1989 [Corrigendum J Clin Invest 83: 1783, 1989].
60. Wolfe BM and Huff MW. Effects of low dosage progestin-only administration upon plasma triglycerides and lipoprotein metabolism in postmenopausal women. J Clin Invest 92: 456-461, 1993.
61. Woods M, Schaefer EJ, Morrill A, Goldin BR, Longcope C, Dwyer JD, and Gorbach SL. Effect of menstrual cycle phase on plasma lipids. J Clin Endocrinol Metab 65: 321-323, 1987.
62. Zambon A, Bertocco S, Vitturi N, Polentarutti V, Vianello D, and Crepaldi G. Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins. Biochem Soc Trans 31: 1070-1074, 2003.